Michio Kaneko
Mito, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Results of a Phase II Trial for Intermediate-Risk Rhabdomyosarcoma Treatment Protocol JRS-I: A Report From the Japan Rhabdomyosarcoma Study Group.
Journal: Pediatric blood & cancer
Published: February 01, 2025
Results of the JRS-I LRA0401 and LRB0402 Japan Rhabdomyosarcoma Study Group trials for low-risk embryonal rhabdomyosarcoma.
Journal: International journal of clinical oncology
Published: January 04, 2024
A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
Journal: Pediatric blood & cancer
Published: January 11, 2023
Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Journal: International journal of clinical oncology
Published: August 05, 2020
Registration-directed phase 1/2 trial of irinotecan for pediatric solid tumors.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: October 01, 2018
Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Journal: International journal of clinical oncology
Published: January 22, 2018
Tailor-made treatment combined with proton beam therapy for children with genitourinary/pelvic rhabdomyosarcoma.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: July 08, 2014
Clinical results of proton beam therapy for advanced neuroblastoma.
Journal: Radiation oncology (London, England)
Published: January 18, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026